Apolipoprotein E–dependent accumulation of Alzheimer disease–related lesions begins in middle age

To study the prevalence and age dependency of senile plaques (SP) and neurofibrillary tangles (NFT), the brain changes characteristic of Alzheimer disease (AD), and their association with apolipoprotein E (APOE) genotypes in a community‐dwelling normal population.

[1]  I. Ferrer,et al.  Interlaboratory Comparison of Assessments of Alzheimer Disease-Related Lesions: A Study of the BrainNet Europe Consortium , 2006, Journal of neuropathology and experimental neurology.

[2]  H. Soininen,et al.  Vascular risk factors, ApoE ϵ4 allele, and gender and the risk of Alzheimer's disease: perspectives on prevention , 2002 .

[3]  Yaakov Stern,et al.  Memory performance in healthy elderly without Alzheimer’s disease: effects of time and apolipoprotein-E , 2001, Neurobiology of Aging.

[4]  E. Boerwinkle,et al.  APOE genotype and cognitive decline in a middle-aged cohort , 2005, Neurology.

[5]  A. Heyman,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1993, Neurology.

[6]  H. Yamaguchi.  Polymorphism in senile dementia of the Alzheimer type from a viewpoint of senile plaque formation , 1998 .

[7]  B. Winblad,et al.  Risk and protective effects of the APOE gene towards Alzheimer’s disease in the Kungsholmen project: variation by age and sex , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  K. Jellinger,et al.  Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study. , 2002, Neurology.

[9]  Kewei Chen,et al.  Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Arto Mannermaa,et al.  Apolipoprotein E 4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease , 2002, Annals of Internal Medicine.

[11]  H. Braak,et al.  A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads , 2004, Acta Neuropathologica.

[12]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.

[13]  J. Price,et al.  Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. , 1998, Archives of neurology.

[14]  H. Braak,et al.  High Frequency of Apolipoprotein E ϵ4 Allele in Young Individuals with Very Mild Alzheimer's Disease-Related Neurofibrillary Changes , 1998, Experimental Neurology.

[15]  C. Iadecola.  Atherosclerosis and neurodegeneration: unexpected conspirators in Alzheimer's dementia. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[16]  J. Haines,et al.  Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease , 1995, Neurology.

[17]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[18]  I. Alafuzoff,et al.  Human Postmortem Brain Tissue and 2-mm Tissue Microarrays , 2006, Applied immunohistochemistry & molecular morphology : AIMM.

[19]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[20]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[21]  C. Pang,et al.  Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology , 2000, Microscopy research and technique.

[22]  J. M. Guralnik,et al.  The role of APOE-&egr;4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging , 2003 .

[23]  Hilkka Soininen,et al.  Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. , 2005, Archives of neurology.

[24]  T. Lehtimäki,et al.  Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. , 1995, Atherosclerosis.

[25]  Ian G. McKeith,et al.  Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales , 2001, The Lancet.

[26]  C. Behl.  Oestrogen as a neuroprotective hormone , 2002, Nature Reviews Neuroscience.

[27]  H. Braak,et al.  Gender and age modify the association between APOE and AD-related neuropathology , 2001, Neurology.

[28]  R. Sulkava,et al.  Incidence of Dementia in Very Elderly Individuals: A Clinical, Neuropathological and Molecular Genetic Study , 2006, Neuroepidemiology.

[29]  A. Hofman,et al.  Apolipoprotein E4 allele in a population–based study of early–onset Alzheimer's disease , 1994, Nature Genetics.

[30]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[31]  M. Albert,et al.  The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. , 2003, Neurology.

[32]  R. Kalaria,et al.  Vascular Factors in Alzheimer's Disease , 2003, International Psychogeriatrics.

[33]  D. Sparks,et al.  Increased density of senile plaques (SP), but not neurofibrillary tangles (NFT), in non-demented individuals with the apolipoprotein E4 allele: comparison to confirmed Alzheimer's disease patients , 1996, Journal of the Neurological Sciences.

[34]  L. Thal,et al.  Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease , 2004, Neurology.

[35]  M. Bobinski,et al.  Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.

[36]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[37]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[38]  G. Alexander,et al.  Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism , 2005 .

[39]  Margaret A. Pericak-Vance,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease , 1997 .

[40]  Philip Thomas,et al.  A review of genome mutation and Alzheimer's disease. , 2006, Mutagenesis.

[41]  P. Schofield,et al.  Memory decline in healthy older people , 2001, Neurology.

[42]  Keith A. Johnson,et al.  Neuropathology of Cognitively Normal Elderly , 2003, Journal of neuropathology and experimental neurology.